{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:42:50Z","timestamp":1788460970289,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"27","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,14]]},"DOI":"10.1093\/eurheartj\/ehu105","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T20:54:25Z","timestamp":1395089665000},"page":"1792-1800","source":"Crossref","is-referenced-by-count":85,"title":["The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial"],"prefix":"10.1093","volume":"35","author":[{"given":"Kausik K.","family":"Ray","sequence":"first","affiliation":[{"name":"Cardiovascular Sciences Research Centre, St George's University of London, Cranmer Terrace, London, SW17 OREUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ditmarsch","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kallend","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Niesor","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Suchankova","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Upmanyu","sequence":"additional","affiliation":[{"name":"Roche Products Ltd, Welwyn Garden City, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Anzures-Cabrera","sequence":"additional","affiliation":[{"name":"Roche Products Ltd, Welwyn Garden City, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Lehnert","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Pauly-Evers","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd, Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingar","family":"Holme","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital, Ulleval, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"\u0160t\u0301\u00e1sek","sequence":"additional","affiliation":[{"name":"Charles University Faculty Hospital, Hradec Kr\u00e1lov\u00e9, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten W. J.","family":"van Hessen","sequence":"additional","affiliation":[{"name":"Groene Hart Ziekenhuis, Gouda, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jones","sequence":"additional","affiliation":[{"name":"Baylor College of Medicine, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the dal-ACUTE Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,3,17]]},"reference":[{"key":"key\n\t\t\t\t20180328180027_EHU105C1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2010.01.008","article-title":"High-density lipoprotein and coronary heart disease: current and future therapies","volume":"55","author":"Natarajan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328180027_EHU105C2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/ncpcardio0500","article-title":"Antiatherogenic small, dense HDL: guardian angel of the arterial wall?","volume":"3","author":"Kontush","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"key\n\t\t\t\t20180328180027_EHU105C3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328180027_EHU105C4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/MOL.0b013e3283468061","article-title":"Metabolic and functional relevance of HDL subspecies","volume":"22","author":"Asztalos","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"key\n\t\t\t\t20180328180027_EHU105C5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328180027_EHU105C6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328180027_EHU105C7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328180027_EHU105C8","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"key\n\t\t\t\t20180328180027_EHU105C9","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1194\/jlr.R800036-JLR200","article-title":"The role of dysfunctional HDL in atherosclerosis","volume":"50","author":"Navab","year":"2009","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20180328180027_EHU105C10","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328180027_EHU105C11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1194\/jlr.D200025-JLR200","article-title":"Analytical performance of a sandwich enzyme immunoassay for pre beta 1-HDL in stabilized plasma","volume":"44","author":"Miida","year":"2003","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20180328180027_EHU105C12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.ahj.2009.09.017","article-title":"Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome","volume":"158","author":"Schwartz","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180328180027_EHU105C13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/oby.20058","article-title":"The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects","volume":"21","author":"Dullaart","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"key\n\t\t\t\t20180328180027_EHU105C14","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1194\/jlr.M008706","article-title":"Modulating cholesteryl ester transfer protein activity maintains efficient pre-beta-HDL formation and increases reverse cholesterol transport","volume":"51","author":"Niesor","year":"2010","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20180328180027_EHU105C15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.bbalip.2013.07.007","article-title":"Evidence for a role of CETP in HDL remodeling and cholesterol efflux: Role of cysteine 13 of CETP","volume":"1831","author":"Maugeais","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180328180027_EHU105C16","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1172\/JCI27602","article-title":"HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway","volume":"116","author":"Matsuura","year":"2006","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180328180027_EHU105C17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/01.ATV.0000143389.00252.bc","article-title":"Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits","volume":"24","author":"Zhang","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20180328180027_EHU105C18","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20180328180027_EHU105C19","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1194\/jlr.M008441","article-title":"Importance of macrophage cholesterol content on the flux of cholesterol mass","volume":"51","author":"Sankaranarayanan","year":"2010","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20180328180027_EHU105C20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2012.02.032","article-title":"Inflammation modulates human HDL composition and function in vivo","volume":"222","author":"de la Llera","year":"2012","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180328180027_EHU105C21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.plipres.2012.03.003","article-title":"Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?","volume":"51","author":"Otocka-Kmiecik","year":"2012","journal-title":"Prog Lipid Res"},{"key":"key\n\t\t\t\t20180328180027_EHU105C22","first-page":"401","article-title":"High density lipoproteins and atherosclerosis: emerging aspects","volume":"9","author":"Sala","year":"2012","journal-title":"J Geriatr Cardiol"},{"key":"key\n\t\t\t\t20180328180027_EHU105C23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ahj.2008.09.022","article-title":"Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients","volume":"157","author":"Bloomfield","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180328180027_EHU105C24","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1111\/j.1755-5922.2010.00221.x","article-title":"Reconstituted HDL in acute coronary syndromes","volume":"30","author":"Chenevard","year":"2012","journal-title":"Cardiovasc Ther"},{"key":"key\n\t\t\t\t20180328180027_EHU105C25","volume-title":"Atherosclerosis","author":"Niesor","year":"2014"},{"key":"key\n\t\t\t\t20180328180027_EHU105C26","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.290.17.2292","article-title":"Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial","volume":"290","author":"Nissen","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328180027_EHU105C27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.297.15.jpc70004","article-title":"Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial","volume":"297","author":"Tardif","year":"2007","journal-title":"JAMA"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/35\/27\/1792\/17153817\/ehu105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:19:05Z","timestamp":1522293545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/35\/27\/1792\/2293025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,17]]},"references-count":27,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2014,3,17]]},"published-print":{"date-parts":[[2014,7,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehu105","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,7,14]]},"published":{"date-parts":[[2014,3,17]]}}}